ClinicalTrials.Veeva

Menu

Regional Central Database Recording of Chronic Myeloid Leukemia (LMC)

I

Institut Bergonié

Status

Unknown

Conditions

Chronic Myeloid Leukemia

Treatments

Other: Practices evaluation

Study type

Observational

Funder types

Other

Identifiers

NCT02869256
IB2014-LMC

Details and patient eligibility

About

It will be a centralized database , multicentre (6 centers) , regional, chronic myelogenous leukemia cases of registration (CML) prospectively and retrospectively.

Full description

Given the complexity and evolution of recommendations and to harmonize these, it appears necessary to establish a central database for recording , monitoring patients with CML supported by the participating centers the region and evaluation of care practices in use .

Indeed , the main purpose of this database is to provide diagnostic and therapeutic management of reported cases of chronic myeloid leukemia and to study the prognostic factors . The main objective is to improve significantly the percentage of patients treated adequately load in the region, in the initial stages of the disease and during its evolution.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic myeloid leukemia Diagnosis (CML) in chronic phase , accelerated or blast
  • male or female patient aged 18 years or more
  • Cases transmitted by referring hematologist , one of the 6 participating centers after patient's oral information
  • Clinical record presented Concertation Meeting LMC Multidisciplinary coordinated by the Institute Bergonié

Exclusion criteria

  • none

Trial contacts and locations

6

Loading...

Central trial contact

Gabriel etienne, MD; Simone Mathoulin-Pelissier, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems